Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by 5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
26	26 Prothena Corp PRTA $352M	346% upside 5 price targets	0
27	27 Kura Oncology KURA $574M	337% upside 5 price targets	0
28	28 Gossamer Bio GOSS $402M	333% upside 3 price targets	0
29	29 Structure Therapeutics GPCR $1.13B	268% upside 4 price targets	0
30	30 Lucid Diagnostics LUCD $126M	266% upside 3 price targets	0
31	31 Dyne Therapeutics DYN $1.36B	265% upside 8 price targets	0
32	32 Lexeo Therapeutics LXEO $224M	261% upside 3 price targets	0
33	TECX 33 Tectonic Therapeutic, Inc. Common Stock TECX $428M	261% upside 3 price targets	0
34	34 Arcturus Therapeutics ARCT $372M	255% upside 3 price targets	0
35	35 Pulmonx LUNG $132M	243% upside 4 price targets	0
36	36 Trevi Therapeutics TRVI $823M	237% upside 4 price targets	0
37	37 Immuneering IMRX $145M	229% upside 4 price targets	0
38	38 PolyPid PYPD $38.1M	221% upside 3 price targets	0
39	39 Edgewise Therapeutics EWTX $1.46B	219% upside 3 price targets	0
40	40 Taysha Gene Therapies TSHA $670M	219% upside 6 price targets	0
41	41 ProQR Therapeutics PRQR $251M	215% upside 4 price targets	0
42	42 Y-mAbs Therapeutics YMAB $197M	206% upside 3 price targets	0
43	43 Cardiff Oncology CRDF $299M	201% upside 3 price targets	0
44	44 Abeona Therapeutics ABEO $337M	199% upside 3 price targets	0
45	45 Viking Therapeutics VKTX $3.62B	197% upside 4 price targets	0
46	46 Biohaven BHVN $1.53B	196% upside 3 price targets	0
47	47 uniQure QURE $853M	191% upside 3 price targets	0
48	HIVE 48 HIVE Digital Technologies HIVE $448M	190% upside 4 price targets	0
49	49 Vir Biotechnology VIR $753M	187% upside 3 price targets	0
50	50 Intellia Therapeutics NTLA $1.24B	185% upside 7 price targets	0

12345

65